PL3262420T3 - Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2 - Google Patents
Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2Info
- Publication number
- PL3262420T3 PL3262420T3 PL16714534T PL16714534T PL3262420T3 PL 3262420 T3 PL3262420 T3 PL 3262420T3 PL 16714534 T PL16714534 T PL 16714534T PL 16714534 T PL16714534 T PL 16714534T PL 3262420 T3 PL3262420 T3 PL 3262420T3
- Authority
- PL
- Poland
- Prior art keywords
- diabetes
- type
- early diagnosis
- diabetic state
- diabetic
- Prior art date
Links
- 206010018429 Glucose tolerance impaired Diseases 0.000 title 1
- 238000013399 early diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL411390A PL411390A1 (pl) | 2015-02-26 | 2015-02-26 | Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2, oraz jej powikłań, w szczególności kardiomiopatii cukrzycowej |
| EP16714534.1A EP3262420B1 (en) | 2015-02-26 | 2016-02-26 | A method for the early diagnosis of a pre-diabetic state and type 2 diabetes |
| PCT/IB2016/051087 WO2016135702A1 (en) | 2015-02-26 | 2016-02-26 | A method for the early diagnosis of a pre-diabetic state and type 2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3262420T3 true PL3262420T3 (pl) | 2019-11-29 |
Family
ID=55661489
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL411390A PL411390A1 (pl) | 2015-02-26 | 2015-02-26 | Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2, oraz jej powikłań, w szczególności kardiomiopatii cukrzycowej |
| PL16714534T PL3262420T3 (pl) | 2015-02-26 | 2016-02-26 | Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL411390A PL411390A1 (pl) | 2015-02-26 | 2015-02-26 | Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2, oraz jej powikłań, w szczególności kardiomiopatii cukrzycowej |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10222384B2 (pl) |
| EP (1) | EP3262420B1 (pl) |
| ES (1) | ES2731294T3 (pl) |
| PL (2) | PL411390A1 (pl) |
| WO (1) | WO2016135702A1 (pl) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007027509A2 (en) * | 2005-08-31 | 2007-03-08 | Biogen Idec Ma Inc. | Evaluating and treating scleroderma |
| JP2010519913A (ja) * | 2007-03-02 | 2010-06-10 | エムディーアールエヌエー,インコーポレイテッド | Wnt遺伝子の発現を抑制するための核酸化合物およびその使用 |
| JP5246870B2 (ja) * | 2009-03-25 | 2013-07-24 | 独立行政法人産業技術総合研究所 | インシュリン産生増強剤 |
| BR112013020274A2 (pt) | 2011-02-10 | 2016-11-22 | Harvard College | substitutos de proteínas pós-traducionalmente modificadas e usos dos mesmos |
-
2015
- 2015-02-26 PL PL411390A patent/PL411390A1/pl unknown
-
2016
- 2016-02-26 US US15/553,575 patent/US10222384B2/en active Active
- 2016-02-26 EP EP16714534.1A patent/EP3262420B1/en active Active
- 2016-02-26 WO PCT/IB2016/051087 patent/WO2016135702A1/en not_active Ceased
- 2016-02-26 ES ES16714534T patent/ES2731294T3/es active Active
- 2016-02-26 PL PL16714534T patent/PL3262420T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3262420A1 (en) | 2018-01-03 |
| US10222384B2 (en) | 2019-03-05 |
| PL411390A1 (pl) | 2016-08-29 |
| US20180017574A1 (en) | 2018-01-18 |
| WO2016135702A1 (en) | 2016-09-01 |
| EP3262420B1 (en) | 2019-03-20 |
| ES2731294T3 (es) | 2019-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3355768A4 (en) | Quantitative heart testing | |
| EP3173027A4 (en) | Heart failure evaluation method and diagnosis device | |
| PL2910178T3 (pl) | Układ do diagnostyki przewodu żołądkowo-jelitowego i sposób sterowania tym układem | |
| GB201719423D0 (en) | Diagnostic tests | |
| IL271534A (en) | Immunosignatures for differential diagnosis | |
| GB201612165D0 (en) | Combinations for the treatment of type 2 diabetes | |
| EP3256859A4 (en) | A biomarker for diagnosing vascular diseases and the uses thereof | |
| GB201507827D0 (en) | Diagnostic test | |
| GB201500875D0 (en) | Antibodies for treatment and diagnosis | |
| GB201402036D0 (en) | Method for determination of the status of a disease | |
| IL267982A (en) | diagnosis | |
| GB2539632B (en) | An apparatus for assisting with the application of a garment | |
| EP3734277A4 (en) | PROCESS FOR EVALUATING A MEDICINAL PRODUCT | |
| GB201508860D0 (en) | Diagnostic method | |
| GB201615753D0 (en) | Diagnostic method | |
| IL251879A0 (en) | A method for diagnosing Niemann-Pick disease using a biomarker | |
| IL258049A (en) | A sensor that allows visualization of a catheter | |
| GB201504297D0 (en) | Diagnosis | |
| GB201509658D0 (en) | Method of diagnosis | |
| PL3262420T3 (pl) | Sposób wczesnego wykrywania stanu przedcukrzycowego lub cukrzycy, zwłaszcza typu 2 | |
| EP3535421C0 (en) | DIAGNOSTIC PROCEDURES | |
| GB201615330D0 (en) | Method of diagnosis | |
| GB201410118D0 (en) | Early diagnosis of leptospire | |
| GB2570772B (en) | Integrity monitor | |
| GB201717509D0 (en) | Method of diagnosis |